NCT00934713View on ClinicalTrials.gov

The Effect of Montelukast Treatment in Wheezy Infants

PHASE4CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Lung Disease, ObstructiveSigns and Symptoms, Respiratory
Interventions
DRUG

montelukast

montelukast 4mg once per day for 8 weeks period

Trial Locations (1)

FIN-00029 HUS

Skin and Allergy Hospital, Helsinki University Central Hospital, Helsinki

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University of Helsinki

OTHER

NCT00934713 - The Effect of Montelukast Treatment in Wheezy Infants | Biotech Hunter | Biotech Hunter